Reference
Tigabu BM, et al. A Cost-effectiveness Analysis of Albumin in Septic Shock: A Patient-level Data Analysis. Clinical Therapeutics : 25 Oct 2019. Available from: URL: https://doi.org/10.1016/j.clinthera.2019.08.023
Rights and permissions
About this article
Cite this article
Fluid resuscitation in septic shock: albumin not worth high cost. PharmacoEcon Outcomes News 841, 18 (2019). https://doi.org/10.1007/s40274-019-6370-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6370-z